harzianic acid: isolated from Trichoderma harzianum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 54691490 |
| SCHEMBL ID | 17022771 |
| SCHEMBL ID | 19130532 |
| MeSH ID | M0234245 |
| Synonym |
|---|
| harzianic acid |
| 2-pyrrolidinepropanoic acid, 3,5-dioxo-alpha-hydroxy-4-(1-hydroxy-2,4-octadienylidene)-1-methyl-alpha-(1-methylethyl)- |
| 157148-06-6 |
| SCHEMBL17022771 |
| SCHEMBL19130532 |
| 2-hydroxy-2-[[(4e)-4-[(2e,4e)-1-hydroxyocta-2,4-dienylidene]-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl]-3-methylbutanoic acid |
| FS-6659 |
| AKOS040735683 |
Harzianic acid is a Trichoderma secondary metabolite. It shows antifungal and plant growth promotion activities.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Harzianic acid is a secondary metabolite of " | ( Bivalent Metal-Chelating Properties of Harzianic Acid Produced by Andolfi, A; Bottiglieri, A; De Tommaso, G; DellaGreca, M; Iuliano, M; Lorito, M; Nicoletti, R; Salvatore, F; Salvatore, MM; Staropoli, A; Vinale, F, 2020) | 2.27 |
| "Harzianic acid is a Trichoderma secondary metabolite, showing antifungal and plant growth promotion activities." | ( Harzianic acid: a novel siderophore from Trichoderma harzianum. Eid, A; Flematti, G; Ghisalberti, EL; Lanzuise, S; Lorito, M; Marra, R; Nigro, M; Ruocco, M; Sivasithamparam, K; Varlese, R; Vinale, F; Woo, SL, 2013) | 2.55 |
| "Harzianic acid (HA) is a T." | ( A novel fungal metabolite with beneficial properties for agricultural applications. Cavallo, P; Lanzuise, S; Lombardi, N; Lorito, M; Manganiello, G; Marra, R; Mazzei, P; Nigro, M; Pascale, A; Piccolo, A; Ruocco, M; Varlese, R; Vinale, F; Woo, SL, 2014) | 1.12 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (65.78) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||